← Insider buys
MPLT

MapLight Therapeutics, Inc. · Healthcare

Chief Discovery Officer Anatol Kreitzer sold $96K of MapLight Therapeutics, Inc.

Sold$96,024
$7.84Price
12,248Shares
−7%Stake

What MPLT did after the filing

Filed Oct 16Copier in Oct 19
The stock from Mon, Oct 19 open, $7.73
+3.1%
S&P 500, same days
−0.9%

4 of 30 trading days so far, to the Oct 23 close.

Traded Thu, Oct 15. Filed Fri, Oct 16, 5:00 PM ET, after the close. Returns use the Oct 19 open and the Oct 23 close. Not investment advice.